Loading candles…
RPG Life Sciences Ltd, incorporated in 2007, operates in the pharmaceutical industry as part of the RPG Group, a diversified Indian conglomerate. The company manufactures and markets formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). Its product offerings include branded formulations, global generics, and synthetic active pharmaceutical ingredients. RPG Life Sciences serves domestic and international markets, with a presence in India and over 50 countries globally. The company holds a leadership position in the Indian immunosuppressant market. It does not have any listed subsidiaries or ventures noted, nor is it currently listed on any stock exchanges based on the available information.
| Type |
|---|
| Details |
|---|
| Date |
|---|
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and dividend | 29 Apr 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 27 Jan 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 25 Jul 2025 |
| Audited Results - Q4 & FY25 | Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a mee… | 28 Apr 2025 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.